More on ONCT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/9/20 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Oncternal Therapeutics Inc. (NQ:ONCT)
Delayed: 8.26 -1.08 (11.56%)
Prev. Close $9.34  
Open$7.91 
52 Wk High$ 
52 Wk Low$ 
Day High$9.08 
Day Low$7.81 
P/E N/A  
EPS$ 
Volume2,803,935 

Friends, Peers and Foes (?): CBAY, MIST, GNMK DRTX (more...)

Apr 7, 2021 09:29 AM Pre-Open Stock Movers 04/07: (SOS) (NMTR) (UTME) Higher; (FGEN) (GEO) (FIXX) Lower (more...)
Apr 6, 2021 05:42 PM After-Hours Stock Movers 04/06: (NMTR) (UTME) (NCLH) Higher; (FGEN) (FIXX) (PHR) Lower (more...)
Apr 6, 2021 04:03 PM UPDATE: Oppenheimer Starts Oncternal Therapeutics (ONCT) at Outperform
Apr 2, 2021 01:29 PM Form PRE 14A Oncternal Therapeutics, For: May 25
Apr 2, 2021 06:05 AM Form S-3 Oncternal Therapeutics,
Mar 30, 2021 08:44 AM Brookline Capital Markets Starts Oncternal Therapeutics (ONCT) at Buy
Mar 22, 2021 04:57 PM Form S-8 Oncternal Therapeutics,
Mar 22, 2021 04:02 PM Form 8-K Oncternal Therapeutics, For: Mar 17
Mar 22, 2021 04:00 PM Form 4 Oncternal Therapeutics, For: Mar 18 Filed by: BREITMEYER JAMES B
Mar 18, 2021 04:38 PM Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with ONCT

View All Entities